Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation
- PMID: 18590693
- PMCID: PMC2929667
- DOI: 10.1016/j.cmet.2008.06.006
Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation
Abstract
The forkhead transcription factor Foxo1 regulates expression of genes involved in stress resistance and metabolism. To assess the contribution of Foxo1 to metabolic dysregulation during hepatic insulin resistance, we disrupted Foxo1 expression in the liver of mice lacking hepatic Irs1 and Irs2 (DKO mice). DKO mice were small and developed diabetes; analysis of the DKO-liver transcriptome identified perturbed expression of growth and metabolic genes, including increased Ppargc1a and Igfbp1, and decreased glucokinase, Srebp1c, Ghr, and Igf1. Liver-specific deletion of Foxo1 in DKO mice resulted in significant normalization of the DKO-liver transcriptome and partial restoration of the response to fasting and feeding, near normal blood glucose and insulin concentrations, and normalization of body size. These results demonstrate that constitutively active Foxo1 significantly contributes to hyperglycemia during severe hepatic insulin resistance, and that the Irs1/2 --> PI3K --> Akt --> Foxo1 branch of insulin signaling is largely responsible for hepatic insulin-regulated glucose homeostasis and somatic growth.
Figures
) with principal component PC1 (A), PC2 (B) or PC3 (C), respectively. The error bars represent the standard deviation. (D–F) Gene expression was independently confirmed by real-time PCR in the liver of 6-week old control (CNTR) and knockout mice (n=3) fasted for 16 hours (−) or fasted and then allowed access to food for 4 hours (+). (D) Expression of genes involved in metabolism, including Gck, Pck1, G6pc and Cpt1a. (E) Expression of genes involved in gene regulation, including Ppargc1a, Fgf21, Srebp1c and Onecut1. (F) Expression of genes involved in animal growth, including Ghr, Igf1, Igfbp1, and Igfals. Data are presented as relative expression of the gene of interest over β-actin (mean ± s.e.m.). * p<0.05 vs CNTR mice under the same feeding condition by Student’s t test.
Comment in
-
The double life of Irs.Cell Metab. 2008 Jul;8(1):7-9. doi: 10.1016/j.cmet.2008.06.010. Cell Metab. 2008. PMID: 18590687 Free PMC article. Review.
References
-
- Altomonte J, Richter A, Harbaran S, Suriawinata J, Nakae J, Thung SN, Meseck M, Accili D, Dong H. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am. J Physiol Endocrinol. Metab. 2003;285:E718–E728. - PubMed
-
- Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic Fibroblast Growth Factor 21 Is Regulated by PPARalpha and Is a Key Mediator of Hepatic Lipid Metabolism in Ketotic States. Cell Metab. 2007;5:426–437. - PubMed
-
- Barthel A, Schmoll D, Unterman TG. FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 2005;16:183–189. - PubMed
-
- Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Aleman JO, Suzuki R, Scapa EF, Agarwal C, Carey MC, Stephanopoulos G, Cohen DE, King GL, Ginsberg HN, Kahn CR. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 2008;7:125–134. - PMC - PubMed
-
- Brown MS, Goldstein JL. Selective versus Total Insulin Resistance: A Pathogenic Paradox. Cell Metab. 2008;7:95–96. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
